3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRID 15MG 0.450 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.45 | KG | 28.057553 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRIDE 15 MG 0.450 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.45 | KG | 28.057553 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1002866/ ADCETRIS BRENTUXIMIB VEDOTINE 50 MG 0.680 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.68 | KG | 28.776978 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1002866/ ADCETRIS BRENTUXIMIB VEDOTINE 50 MG 0.680 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.68 | KG | 28.776978 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRID 15MG 0.450 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.45 | KG | 28.057553 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 2004375 OPDIVO NIVOLUMIB 100/MG 10ML WEIGHT 0.600 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.6 | KG | 1518.345323 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 2004375 OPDIVO NIVOLUMIB 100/MG 10ML WEIGHT 0.600 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.6 | KG | 1518.345323 | United Kingdom | KPFI |
3/29/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSING PONATINIB HYDROCHOLRIDE 15 MG 0.450 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.45 | KG | 28.057553 | United Kingdom | KPFI |
3/25/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1023749/ ICLUSIG PONATINIB HYDROCHLOLRIDE 15 MG 450 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.45 | KG | 28.022274 | United Kingdom | KPFI |
3/25/2024 | 30049099 | MEDICINE ALREADY EXAMINED AND RELEASED DELIVERY TO CANCER PATIENT MEDICINE SUPPLIED FREE OF COST AS PER ACCESS PROGRAM- 1021801/ CAMPATH ALEMTUZUMAB 30 MG 0.38 KGS NON COMMERCIAL | CLINIGEN HEALTHCARE LTD | 0.38 | KG | 22.274115 | United Kingdom | KPFI |